logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

KN HOSPITAL (02120) repurchased 68,600 shares on October 22 for approximately HK$779,800.

date
19:48 22/10/2026
avatar
GMT Eight
KN Hospital (02120) announced that on October 22, 2026, it repurchased 68,600 shares for approximately HK$779,800.
KN HOSPITAL (02120) announced that on October 22, 2026, it repurchased 68,600 shares for approximately HK$779,800.
Related Articles
IPO Insight | Mufemilast commercialization begins, Hemei Pharmaceutical's 18A listing enters countdown
HK Stock
TRANSTHERA-B (02617) repurchased 5,500 shares on October 22 at a cost of approximately HK$47,200.
HK Stock
Xinhua Winshare Publishing & Media (00811) will distribute an interim dividend of HK$0.198334 per share on December 22.
IPO Insight | Mufemilast commercialization begins, Hemei Pharmaceutical's 18A listing enters countdown
TRANSTHERA-B (02617) repurchased 5,500 shares on October 22 at a cost of approximately HK$47,200.
HK Stock
Xinhua Winshare Publishing & Media (00811) will distribute an interim dividend of HK$0.198334 per share on December 22.
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.